Skip to main content
Clinical Trials/NCT04193085
NCT04193085
Completed
N/A

Wearable Technology to Assess Gait Function in Spinal Muscle Atrophy and Duchenne Muscular Dystrophy

Columbia University1 site in 1 country39 target enrollmentNovember 25, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinal Muscular Atrophy Type 3
Sponsor
Columbia University
Enrollment
39
Locations
1
Primary Endpoint
Validation of Instrumented Insoles: Circle Walking
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab settings 39 during a single visit in people with SMA (13), DMD (13) and healthy controls (13) and in 15 participants in real-life environments.

Detailed Description

Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are genetic disorders that often result in progressive weakness and impaired function. Results from this study will help characterize how gait is affected in SMA and DMD. This novel device can serve as a more affordable and versatile measurement instrument for neuromuscular disorders that affect gait and balance. All participants will be observed and measured while wearing the instrumented insoles in the lab and in real-life environments.

Registry
clinicaltrials.gov
Start Date
November 25, 2019
End Date
August 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jacqueline Montes

Assistant Professor of Rehabilitation and Regenerative Medicine , Rehab & Regenerative Med PT

Columbia University

Eligibility Criteria

Inclusion Criteria

  • One of the following categories:
  • Genetic confirmation of spinal muscular atrophy
  • Genetic confirmation of Duchenne or Becker muscular dystrophy or evidence on muscle biopsy with a clinical presentation consistent with DMD/BMD
  • Healthy individuals.
  • Able to walk independently at least 25 meters

Exclusion Criteria

  • Unable to walk 25 meters independently.
  • Use of investigational medications intended for the treatment of SMA or DMD/BMD within 30 days prior to study entry.

Outcomes

Primary Outcomes

Validation of Instrumented Insoles: Circle Walking

Time Frame: Baseline

To measure spatial parameters, kinetic parameters, temporal parameters, and metrics of cumulative activity in order to compare against the gold standard instrumented walkway participants will be asked to walk a series of half-circles on the instrumented walkway.

Muscle Strength Testing with Hand-held Dynamometry (HHD)

Time Frame: Baseline

HHD is used to assess strength of selected muscles.

Validation of Instrumented Insoles: Six Minute Walk Test

Time Frame: Baseline

To measure spatial parameters, kinetic parameters, temporal parameters, and metrics of cumulative activity in order to compare against the gold standard instrumented walkway participants will complete the Six Minute Walk Test. This test is an objective evaluation of functional exercise capacity, measures the maximum distance a person can walk in six minutes over a 25 meter course. This will be performed in a corridor and include the instrumented walkway.

Validation of Instrumented Insoles: 10 Meter Walk/Run

Time Frame: Baseline

To measure spatial parameters, kinetic parameters, temporal parameters, and metrics of cumulative activity in order to compare against the gold standard instrumented walkway, participants will walk, or run if able to, for 10 meters on the instrumented walkway.

Validation of Instrumented Insoles: Time Up and Go Test (TUG)

Time Frame: Baseline

To measure spatial parameters, kinetic parameters, temporal parameters, and metrics of cumulative activity in order to compare against the gold standard instrumented walkway, participants will complete the TUG test. This test is designed to test mobility after a person stands up from a seated position. This will be completed on the instrumented walkway.

Validation of Instrumented Insoles: Straight Line Walking

Time Frame: Baseline

To measure spatial parameters, kinetic parameters, temporal parameters, and metrics of cumulative activity in order to compare against the gold standard instrumented walkway, participants will be asked to walk in a straight line multiple times over the instrumented walkway.

Secondary Outcomes

  • Free-living Testing of Instrumented Insoles(One week)

Study Sites (1)

Loading locations...

Similar Trials